Skip to content

Evaluation of the effect of cupping on clinical symptoms of adult asthma 18-60 years

The effect of wet cupping on clinical manifestation of the adult asthma 18-60 ?years ?

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181110041600N1
Enrollment
72
Registered
2020-07-15
Start date
2020-07-22
Completion date
Unknown
Last updated
2020-08-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild to moderate asthma. Asthma

Interventions

Intervention 1: Intervention group: The intervention group is being treated with standard asthma medications, which will use 25.25 micrograms of 2 puff serum sprays every 12 hours, and if needed, they

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Patients with mild to moderate asthma are diagnosed by a pulmonary specialist. Patients with stable conditions. The patient's age is 18 to 60 years old.

Exclusion criteria

Exclusion criteria: Patients with severe asthma and need hospitalization Patients with underlying conditions such as CF, bronchopulmonary, dysplasia, heart failure, pulmonary embolism, bronchotracheomalacia, bronchiectasis, sarcoidosis, and diabetes Consumer of drugs such as aspirin, beta-blockers and NSAIDs Cupping less than a month Patients with a history of coagulation disorders Patients with a history of anemia Weak immune system Smokers Breastfeeding Pregnancy Inability to speak Persian

Design outcomes

Primary

MeasureTime frame
Evaluation of clinical symptoms of patients with mild to moderate asthma. Timepoint: At week zero and at the end of weeks one, two, four, six and eight. Method of measurement: Asthma Control Test.

Secondary

MeasureTime frame
Evaluation of clinical symptoms of patients with mild to moderate asthma. Timepoint: In the week of zero and at the end of the first, second, fourth, sixth and eighth weeks. Method of measurement: Asthma control questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAbbas Joushan

Shahid Beheshti University of Medical Sciences

dr.a.joushan@sbmu.ac.ir+98 21 8877 3521

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026